NYSE · Biotech stocks database
ABT — Abbott Laboratories
ABT (Abbott Laboratories) stock: $103.22, $178.61B market cap, $5.10B cash, $203.14B EV, $183.11B fully diluted market cap. Next expected readout: Oct-26. Data from Fully Diluted's biotech stocks database.
Overview
Assets
Pipeline
Trials
Holders
Enterprise value
$203,144.2M
Balance sheet
Cash $5,104.0M Debt $29,638.0M Net cash -$24,534.0M Enterprise value $203,144.2M Basic shares 1,743.0M shares Fully diluted shares 1,773.9M shares Fully diluted market cap $183,106.4M Cash per share $2.93
Cash figures as of 2026-06-30. Database snapshot: 2026-09-22.
Price history Loading ABT daily closes…
Loading price history…
Upcoming catalysts Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.
Full readout calendar →
Asset data not yet available for this company.
No lead program on file for this company.
Active clinical trials Trial Phase Status Role Sponsor BP Condition(s) Mgmt guide NCT06668935 Not disclosed Recruiting Sponsor ABT — Diabetes Mellitus — NCT07421076 Not disclosed Recruiting Sponsor ABT — Paroxysmal Atrial Fibrillation (PAF) — NCT06921902 Not disclosed Recruiting Sponsor ABT — Pre Diabetes — NCT06436053 Not disclosed Recruiting Sponsor ABT — Heart Failure — NCT04959552 Not disclosed Active, not recruiting Sponsor ABT — Diabete Mellitus — NCT05061004 Not disclosed Recruiting Sponsor ABT — Mitral Regurgitation — NCT07373353 Not disclosed Recruiting Sponsor ABT — Ischemic Heart Disease (IHD) — NCT06595615 Not disclosed Enrolling by invitation Sponsor ABT — Cardiac Disease — NCT07509658 Not disclosed Recruiting Sponsor ABT — Tricuspid Regurgitation — NCT05932615 Not disclosed Enrolling by invitation Sponsor ABT — Aortic Valve Stenosis; Heart Valve Diseases; Aortic Valve Disease — NCT06423430 Not disclosed Recruiting Sponsor ABT — Treatment Resistant Depression — NCT07256925 Not disclosed Recruiting Sponsor ABT — Malnutrition, Calorie; Sarcopenia —
Sponsor-matched active trials from ClinicalTrials.gov (85 as sponsor, 100 as collaborator); "Sponsor" = company is the lead sponsor, "Collaborator" = company is a collaborator. The BP column flags big-pharma involvement as lead sponsor or collaborator (excluding the company itself). The Mgmt guide column shows what management guided for readout timing when a guided program matches the trial (hover for the quote, click for the source). Trial listings are not a company pipeline slide.
View all 185 active trials for Abbott Diabetes Care on ClinicalTrials.gov
No specialist-fund holders in 13F data for this company.
Fully Diluted · Free biotech stocks database. Figures are sourced from SEC filings and company disclosures; not investment advice.